Myxovirus resistance, osteopontin and suppressor of cytokine signaling 3 polymorphisms predict hepatitis C virus therapy response in an admixed patient population: comparison with IL28B

Myxovirus resistance, osteopontin and suppressor of cytokine signaling 3 polymorphisms predict hepatitis C virus therapy response in an admixed patient population: comparison with IL28B

OBJECTIVES: Suppressor of cytokine signaling 3, myxovirus resistance protein and osteopontin gene polymorphisms may influence the therapeutic response in patients with chronic hepatitis C, and an association with IL28 might increase the power to predict sustained virologic response. Our aims were to...

Description complète

Détails bibliographiques
Auteurs principaux: Ana Luiza Dias Angelo, Lourianne Nascimento Cavalcante, Kiyoko Abe-Sandes, Taisa Bonfim Machado, Denise Carneiro Lemaire, Fernanda Malta, Joao Renato Pinho, Luiz Guilherme Costa Lyra, Andre Castro Lyra
Format: Article
Langue:English
Publié: Elsevier España 2013-10-01
Collection:Clinics
Sujets:
Hepatitis C
IL28B
MxA
Osteopontin
SOCS3
Genetic polymorphisms
Accès en ligne:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322013001001325&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322013001001325&lng=en&tlng=en

Documents similaires